SCHEMBL1014777

SCHEMBL1014777

COC(=O)c1cc(Cl)ccc1NC(=O)COCC(=O)N(c1ccccc1)C1CCCCC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
KDM4E B2RXH2 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
NPC1 O15118 1/20 0.46
MITF O75030 1/20 0.46
RAB9A P51151 1/20 0.46
PAX8 Q06710 1/20 0.46
POLB P06746 2/20 0.44
MAPT P10636 5/20 0.43
LMNA P02545 2/20 0.43
GAA P10253 2/20 0.43
TRPM8 Q7Z2W7 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
SERPINE1 P05121 1/20 0.43
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1014856 0.92 SERPINE1 (0.51) ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL1015239 0.91 SERPINE1 (0.50) ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL1015240 0.89 MEN1 (0.46) ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL1013555 0.87 KMT2A (0.48) ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL1799240 0.83 MAPT (0.49) ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL1015912 0.80 RAB9A (0.55) ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL1015397 0.79 SERPINE1 (0.50) ALDH1A1KDM4EMEN1KMT2APOLB
SCHEMBL1013771 0.78 SERPINE1 (0.49) ALDH1A1KDM4EMEN1KMT2APOLB
SCHEMBL1015370 0.77 KDM4E (0.60) ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL1013722 0.76 SERPINE1 (0.52) ALDH1A1KDM4ENPC1MITFMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 ALDH1A1 888/4885KDM4E 4108/4885SMN1; SMN2 2290/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.